Tenet Earnings: Significant Hospital Margin Expansion Boosts 2025 Outlook
If more uninsured people seek care at Tenet hospitals, the company’s uncompensated care costs may rise and pressure profits.

Key Morningstar Metrics for Tenet Healthcare
- Fair Value Estimate: $160.00
- Morningstar Rating: ★★★
- Morningstar Economic Moat Rating: Narrow
- Morningstar Uncertainty Rating: High
What We Thought of Tenet Healthcare’s Earnings
Tenet Healthcare’s THC second-quarter results outperformed management’s profit goals, and the company raised its profit guidance for 2025, including adjusted EBITDA by about 10% and adjusted earnings per share by over 25%. The shares declined 5% after the July 22 call, though.
Why it matters: The share drop may reflect investor concerns that Tenet’s results are peaking after benefiting in recent years from elevated medical utilization trends and significant margin expansion, the latter of which drove the company’s strong profit performance in the quarter and its higher 2025 outlook.
- Quarterly revenue growth of about 3% looked roughly in line with expectations, while operating margin expanded by nearly 300 basis points, driven primarily by strong same-store hospital growth, favorable payer mix, and cost controls in the hospital operations.
- Despite these strong results, investors appear concerned that pending policy changes may eventually reverse some of those trends, especially if the uninsured rate rises on new Republican policy initiatives.
The bottom line: While we have raised our 2025 expectations, we remain cautious about our intermediate- and long-term expectations for Tenet, and we are keeping our $160 fair value estimate intact. We continue to view the shares as about fairly valued.
- In early 2025, we upgraded our moat rating to narrow from none based on the company’s intangible asset-related advantages; this drove our March valuation increase.
- However, we think investors should recognize the high uncertainty around Tenet’s future cash flows, especially considering how pending policy changes could constrain profit growth in the intermediate term.
Coming up: The insured rate may decline if new Republican policies materially cut into the number of members on the individual exchanges (starting in 2026) and Medicaid (2027.) If more uninsured people seek care at Tenet hospitals, the company’s uncompensated care costs may rise and pressure profits.
Editor’s Note: This analysis was originally published as a stock note by Morningstar Equity Research.
This article was generated with the help of automation and reviewed by Morningstar editors. Learn more about Morningstar’s use of automation.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.
